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Abstract 
 
Purpose 
 
 To investigate the outcomes of digital nerve repairs using processed nerve allograft for 
defects measuring 30 millimeters or less. 
 
Methods 
 
 Seventeen patients with 21 digital nerve lacerations in the hand underwent 
reconstruction with processed nerve allograft. Outcome data for 14 patients with 18 digital nerve 
lacerations were available for analysis. Postoperative outcome data were recorded at a 
minimum of 12 months and an average of 15 months. The average nerve gap measured 11 mm 
(range, 5 - 30 mm). Outcome measures included postoperative sensory examination as 
assessed by Semmes-Weinstein monofilaments and static- and moving-2 point discrimination. 
Pain was graded using a visual analog scale throughout the recovery period. In addition, 
patients completed the Quick Disabilities of the Arm, Shoulder, and Hand survey pre- and 
postoperatively. 
  
 
Results 
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 Using Taras outcome criteria, 7 of 18 (39%) digits had excellent results, 8 of 18 (44%) 
had good results, 3 of 18 (17%) digits had fair results, and none had poor results. At final follow-
up, Semmes-Weinstein monofilament testing results ranged from .08 grams to 279 grams. Quick 
Disabilities of the Arm, Shoulder, and Hand scores recorded at the patient’s first postoperative 
visit averaged 45 (range, 2-80), and final scores averaged 26 (range, 2-43). There were no signs 
of infection, extrusion, or graft reaction. 
 
 
Conclusions 
  
 The data suggest that processed nerve allograft provides a safe and effective alternative 
for the reconstruction of peripheral digital nerve deficits measuring up to 30 mm. 
 
Type of Study/Level of Evidence: Therapeutic IV 
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Introduction 
 
 Restoration of peripheral nerve function continues to challenge surgeons despite 
advances in manufactured and traditional graft options and refined surgical techniques. (1,2,3) 
Segmental nerve loss often accompanies trauma to the hand making a tension-free, end-to-end 
repair impossible. In many cases, traumatic nerve injury requires debridement of the nerve ends, 
which further compromises tension-free repair. (4) In cases in which a secure, tension-free 
repair is not possible, the most common recommendation has been to graft the defect with a 
segment of autologous nerve. Autografts provide a reliable structure and environment through 
which axons can regenerate across a deficit. However, disadvantages include prolonged 
operative times, higher facility costs, and donor site morbidity which may include pain, scarring, 
neuroma formation, and sensory loss. (5,6,7,8) 
 Autograft alternatives include allografts and artificial nerve conduits, which eliminate 
donor site morbidity. Several clinical studies have documented the effectiveness of nerve 
conduits for short gaps (9); however, the clinical value of nerve conduits to bridge larger gaps 
remains unclear. (3,9) Recent advances in allograft tissue processing have eliminated the need 
for immunosuppression, and allografts are becoming an attractive alternative to autografts and 
conduits. (10,11,12) 
 Several authors have reported success with processed nerve allografts. (1,2,13,14) One 
such allograft is the Avance® processed nerve graft (AxoGen, Inc., Alachua, FL). It consists of 
human nerve that has been decellularized, gamma irradiated, and subjected to enzymatic 
degradation of chondroitin sulfate proteoglycans with chondroitinase. As a result, the allograft is 
rendered nonimmunogenic while its 3-dimensional structure is maintained. (14,15) Animal 
studies have shown this material to mimic autografts in macrostructure, 3-dimensional 
microstructural scaffolding, and protein composition. Theoretically, these qualities render 
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allograft an effective material to span peripheral nerve defects. (1,4,16) A recent review of the 
literature, however, disclosed few clinical studies evaluating the efficacy of processed allografts 
to reconstruct digital nerve defects in the hand. (14,17) In a retrospective review, Karabekmez et 
al (14) reported on the efficacy of processed allografts for restoring adequate sensation in nerve 
defects ranging from 5 to 30 mm. Cho et al (17) reported on a subset of digital nerve defects up 
to 40 mm from an ongoing nerve registry. 
 The goal of this prospective study was to evaluate the clinical outcomes of digital nerve 
gaps in the hand measuring 30 mm or less reconstructed with processed nerve allograft. 
 
Methods 
 After receiving institutional review board approval, a prospective study was conducted on 
patients older than 18 years of age with digital nerve lacerations not amenable to primary repair. 
(Table 1) Nerve reconstruction was performed using a commercially available processed nerve 
allograft (Avance® Nerve Graft, AxoGen, Inc., Alachua, FL) 
 
Surgical Technique 
 When a nerve laceration was identified during surgery, the gap between the debrided 
ends was measured with the digits extended. If the gap was 5 mm or greater, then a nerve 
allograft was used to reconstruct the defect. The injured proper digital nerve’s diameter was 
consistently 2-3 mm. Each processed nerve allograft was prepared following the packaged 
instructions for use. Under loupe magnification, the allograft was trimmed to match the defect, 
and 8-0 nylon suture was used to secure the graft junctures. Typically, 3 simple sutures secured 
each juncture. (Figure 1)  
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Figure 1. The completed nerve reconstruction with allograft in place. 
 
Saline irrigation was used to clear the surgical field after release of the tourniquet and 
achievement of hemostasis. After wound closure, a plaster orthosis was applied over a sterile 
gauze bandage. After the first postoperative visit, the orthosis was discontinued, flexion as 
tolerated was allowed but extension was limited to neutral. 
 
 
Outcome Measurement 
 Seventeen patients with 21 digital nerve reconstructions met this study’s inclusion 
criteria. One hand surgeon performed all surgeries. One hand therapist who was not blinded 
recorded the outcome data. Final outcome data were recorded at least 12 months 
postoperatively. Primary outcome measures included postoperative sensory examination using 
Semmes-Weinstein, where lower values for touch-pressure detection thresholds indicate a less 
severe degree of nerve dysfunction (18) and static- (S2PD) and moving- (M2PD) 2-point 
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discrimination using the Disk-Criminator to assess sensibility (Sensory Management Services 
LLC, Lutherville, MD). 
 Patients completed the Quick DASH (Disabilities of the Arm, Shoulder, and Hand) (19) 
survey pre- and postoperatively to quantify their pain perception and functional impairment. 
Quick DASH scores range from 0 indicating no disability to 100 describing the most severe 
disability. Pain was recorded on a 10-point visual analog scale, where a score of 0 denoted no 
pain, and a score of 10 signified extreme pain. Secondary outcome measures included patient 
demographics, comorbidities, hand dominance, and location and mechanism of injury. 
Postoperative complications were reported. The Taras measurement outcome score was used 
to grade results as excellent, good, fair, or poor. (Table 2) (20)  
 The Taras scale attempts to account for outcomes in which either S2PD or M2PD is 
greater than 8 mm but is not a “Good” result. Taras et al stated that because digital width is 
finite, 2-point discrimination greater than 8 mm could not be determined accurately without 
entering the nerve distribution of the contralateral digital nerve and reported 2-point 
discrimination greater than 8 mm with a score of “>8”. Moving- and static 2-point discrimination 
do not always recover synchronously to the same level; thus, the lesser of a nerve’s 2 
measurements was chosen to assign it to its appropriate group in the final statistical analysis. 
 
 
 
Results 
 Seventeen patients with 21 digital nerve lacerations underwent digital nerve allograft 
reconstruction. Three patients did not complete the study’s 12-month minimum follow-up 
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requirement. As a result, the study cohort included 14 patients with 18 digital nerve 
reconstructions. Ten men and 4 women with an average age of 39 years (range, 18–76 years) 
returned for follow-up examination and outcome reporting through at least 12 months after 
surgery. Eleven injuries involved the dominant hand, and 7 injuries affected the nondominant 
hand. Mechanisms of injury are reported in Table 1. There were concomitant fractures of the 
involved digit in 7 patients and 9 tendon lacerations in the involved digit in 7 patients. The 
average interval from injury to surgery was 29 days (range, 2–262 days). The average nerve 
defect measured 11 mm in length (range, 5 - 30 mm). The average time to final follow-up was 15 
months (range, 12-20 months). At final follow-up, Semmes-Weinstein monofilament testing 
ranged from .08 grams to 279 grams. Average S2PD results were 7.1 mm (range, 5-8 mm), and 
average M2PD results were 5.4 mm (range, 2-8 mm). 
 Results were graded using the scale reported by Taras (20), a modification of the scale 
used by Weber (Table 2). (3) According to this scale, 7 of 18 (39%) digits had an excellent 
result, 8 (44%) had good results, 3 (17%) digits had fair results, and none had poor results. 
Using the Weber classification for comparison purposes, 7 of 18 (39%) digits had an excellent 
result, 7 (39%) digits had good results, and 4 (22%) had poor results. Initial Quick DASH scores 
recorded at the patient’s first postoperative visit averaged 45 (range, 2-80), and final Quick 
DASH scores averaged 26 (range, 2-43). There were no signs of infection, extrusion, or graft 
reaction. Using the visual analog scale, pain averaged 2 at final follow-up compared to 5 initially. 
One patient underwent additional surgery for a 2-stage tendon reconstruction. 
 
 
Discussion 
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 Despite the options available to reconstruct nerve defects, treatment of peripheral nerve 
gap injuries remains challenging. Traditionally, nerve autografts have been advocated to 
reconstruct peripheral nerve defects not amenable to primary repair, but donor site 
comorbidities, increased operative times, and limited harvest sites have presented considerable 
limitations. (5,6,7,8) Early results of processed allografts have been encouraging and provide an 
attractive alternative to autografts. (1,17) Manufactured grafts eliminate donor site morbidity 
issues while retaining the elements that promote cell migration into the graft. (2,15,16)  
 Published studies have presented alternatives to autografts for nerve defects extending 
up to 20 mm. In 2000, Weber et al (3) conducted a randomized, controlled study to examine the 
outcomes of nerve conduits compared with direct suture and autograft for sensory digital nerve 
repairs. For nerve gaps 4 mm or less, they reported mean M2PD 3.7 +/- 1.4 mm for conduit 
repair and 6.1 +/- 3.3 mm for end-to-end repairs (P = 0.03). The mean M2PD for nerve gaps 
greater than 8 mm for conduits was 6.8 +/- 3.8 mm. Taras (20) et al also demonstrated the 
efficacy of purified type 1 bovine collagen conduits in a prospective study of 22 isolated digital 
nerve lacerations at a mean gap of 12 mm. They reported mean M2PD and S2PD of 5.0 and 5.2 
mm, respectively, for digits with measurable recovery at the mean final follow-up 20 months 
(range, 12-59 months) after surgery; however, 6 nerve repairs failed to recover S2PD and were 
excluded from the mean analysis of S2PD. According to the grading criteria used in the Taras 
study, 13 of 22 (59%) digits achieved excellent results, 3 (14%) digits had good results, 6 (27%) 
digits had fair results, and there were no poor results. Rinker et al (21) showed no clinical 
difference between polyglycolic nerve conduits and autogenous vein grafts for repair of 
peripheral nerve defects at a mean gap of 10 mm. The Multicenter Retrospective Study of 
Avance® Nerve Graft Utilization, Evaluations and Outcomes in Peripheral Nerve Injury Repair 
represents the largest retrospective review of processed allografts to date. The multicenter, 
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multisurgeon review showed that use of processed allografts is a reliable method to restore 
nerve function across nerve gaps 5-50 mm in length. (1) 
 The current study presents the results of a prospective series demonstrating the clinical 
efficacy of processed nerve allografts to repair digital nerve defects measuring up to 30 mm 
(average 11 mm) in length. The results of the current study are similar to others in the literature 
(1,2,3,10,12,13,14,15,16,21) but are expanded to include the patient's perception of their 
functional limitations. In the current study, postoperative Quick DASH scores improved by an 
average of 18 points, representing a 42% reduction from preoperative scores. According to 
Hunsacker et al (22), a DASH score of 10 +/- 15 falls within normal limits for the US general 
population. Few studies to date have assessed the minimum clinically important difference 
(MCID) of the QuickDASH. Mintken et al (23) reported that the MCID was 8 points in shoulder 
patients. Sorensen et al (24) defined MCIDs for the DASH, Quick DASH, and Patient-Rated 
Wrist Evaluation questionnaires for group-level analysis of atraumatic conditions of the hand, 
wrist, and forearm, with the Quick Dash having an MCID of 14 points. For individual digits in the 
current study, the average difference between initial and final Quick DASH scores were thumb 
(n=7) 19, index (n=4) 12, middle (n=2) 28, ring (n=1) 48, and small finger (n=4) 12. A limitation of 
the QuickDASH rating instrument is that the score reflects concomitant injuries, which in many 
cases accounted for a greater degree of disability than did the nerve injury. 
 The correlation coefficients (r-values) for S2PD and M2PD were 0.36 and 0.74, 
respectively. The coefficients of determination (R Squared) for S2PD and M2PD are 0.13 and 
0.55, respectively. The higher the coefficient of determination, the higher the proportion of 
variation of the dependent variable is interpreted by the independent variable. (25,26) For S2PD, 
this indicates a very poor correlation, and just 13% of the data is explained, which means that for 
recovery of sensibility, there is very little evidence to support a relationship between Semmes 
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Weinstein monofilament testing and 2-point discrimination. For M2PD, 55% of the variation in 
the dependent variable is explained by the independent variable. (Figure 2)  
 
Figure 2. Comparisons of Semmes-Weinstein monofilament testing with static- and moving 2-
point discrimination by repair. The linear coefficients of determination (R2) for S2PD and M2PD 
were 0.13 and 0.55, respectively. 
 
As anticipated the 2-point discrimination measures showed little correlation to the monofilament 
testing. 
 No postoperative complications such as infection or graft rejection occurred. One 
patient underwent an additional surgery for a 2-stage tendon reconstruction after failed 
primary tendon repair on the same digit as the nerve allograft, but the nerve allograft 
was not exposed during that procedure. 
 Debate exists about the best material and technique to repair digital nerve defects. One 
advantage of allografts compared to nerve conduits is the similarity between allografts and 
autografts in terms of 3-dimensional macro- and microstructure. Whitlock et al (16) compared 
Avance® processed allografts to type 1 collagen conduits and isografts (autograft) in a rat 
model. They demonstrated that processed allografts were superior to conduits for short (14 mm) 
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and long (28 mm) nerve gaps. Nerve conduit provides a hollow macrostructure and allows for 
collection of fibrin within the inner chamber to serve as the scaffold for axonal regeneration 
towards the distal stump. It lacks the internal microstructure and extracellular matrix of native 
nerve tissue. Whitlock et al (16) suggested that the basal laminal internal structure retained by 
advances in allograft processing enhances its nerve regeneration potential. A subsequent study 
quantified the nerve fiber density between allograft, nerve conduits, and isograft. Nerve conduits 
exhibited a consistent decrease in midgraft density compared to allografts and isografts for both 
short and long graft models. In addition, the nerve fibers were distributed in an unorganized 
pattern for conduits, whereas allografts and isografts demonstrated evenly distributed nerve fiber 
regeneration. (13) 
 One limitation of the current study is the small sample size. An unblinded, hand therapist 
collected all outcome data, thus, it is impossible to quantify the impact of observer bias on the 
results. Future investigation with prospective randomized studies to compare allografts to nerve 
conduits would further delineate the value of these techniques. In addition, the performance of 
nerve allografts to bridge motor nerve gaps longer than 20 mm would further delineate the 
indications for this type of graft. 
 Pricing for processed Avance® nerve allograft is comparable to hollow-tube collagen 
conduits and is less than the costs associated with autograft harvest (including additional 
operating room time, physician time, and anesthesia time). At one of the hospitals where this 
series’ nerve reconstructions were performed, Avance® nerve graft cost approximately $1550 
for all lengths, and the estimated cost of similar lengths of collagen conduit ranged from $1,385 
to $1470. The added expense that autograft harvest adds to a procedure can easily exceed the 
cost of off-the-shelf processed nerve allograft or hollow-tube conduit. Estimated OR cost per 
minute varies greatly from hospital to hospital, but published costs of operating room time (27) 
ranges from $65 - $166 per minute exclusive of physician and anesthesia fees. 
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Table 1. Nerve Repair Patient Data 
 
 
 
 
Table 2. 
 
Taras and Weber Grading Scales for 2-Point Discrimination 
Patient Age Sex 
Affected 
Side Mech Inj Digit 
Nerve 
Injured 
Gap 
Lengt
h 
(mm) 
Final 
Follow-
Up 
(mos) S2PD M2PD 
SW 
(gm) 
 Initial 
Pain  
Final 
Pain 
Initial 
QuickDASH 
Score 
Final 
Quick
DASH 
Score 
Difference 
in 
QuickDASH 
Taras 
Graded 
Results 
 
Weber 
Graded 
Results 
1 25 Female Dominant Ceramic Thumb RDN 10 25 8 4 .17 5 1 27.3 2.3 25.0 E E 
   
  
 
UDN 10 25 8 4 .17 5 1 27.3 2.3 25.0 E E 
2 31 Female Nondominant Knife Small UDN 10 15 5 4 .08 1 1 2.3 2.3 0.0 E E 
3 19 Male Nondominant Circular saw Thumb UDN 10 12 7 5 .17 2 1 65.9 43.2 22.7 G G 
4 69 Male Dominant Circular saw Small UDN 6 12 6 4 2.36 3 1 29.5 22.7 6.8 E E 
5 39 Male Dominant Saw Long UDN 17 23 8 8 279 5 8 79.5 50.0 29.5 F P 
6 29 Male Nondominant Circular saw Small UDN 28 13 8 8 .45 7 1 34.1 11.4 22.7 F P 
7 54 Male Dominant Sheet metal Index RDN 10 16 8 6 .45 3 3 56.8 43.2 13.6 G G 
8 57 Male Nondominant Table saw Thumb RDN 10 12 6 4 .17 3 1 43.2 36.4 6.8 E E 
   
  
 
UDN 10 12 6 4 .17 3 1 43.2 36.4 6.8 E E 
9 22 Female Dominant Glass Thumb RDN 10 12 8 5 .22 4 2 61.4 38.6 22.8 G G 
   
  
 
UDN 10 12 6 5 .22 4 2 61.4 38.6 22.8 G G 
10 29 Male Nondominant Knife Index RDN 5 12 5 2 .08 8 1 11.4 6.8 4.6 E E 
11 18 Male Nondominant Glass Ring RDN 12 15 7 8 279 10 1 65.9 18.2 47.7 G P 
12 57 Male Dominant Tape measure Index RDN 7 17 8 7 .17 5 2 61.4 34.1 27.3 G G 
   
  
 
RDN 5 17 8 7 .17 5 2 61.4 34.1 27.3 G G 
13 24 Male Dominant Steel cable Index UDN 30 12 8 8 279 4 4 29.5 27.3 2.2 F P 
14 76 Female Dominant Glass Small UDN 5 12 8 5 .08 5 1 44.5 26 18.5 G G 
Avg 39         11 15 7 5 
 
5 2 44.8 26.3 18.4    
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Taras 
Weber 
Grade Moving 2-
Point 
Discrimination 
(mm) 
 
Static 2-Point 
Discrimination 
(mm) 
Moving 2-
Point 
Discrimination 
(mm) 
 
Static 2-Point 
Discrimination 
(mm) 
Excellent < 4  or < 6  < 4  or < 6  
Good 5 - 7  
or 
7 5 - 7  or 7 - 15  
Fair 8  or 8  
 
Poor 
 
>8  and > 8   ≥8  or  ≥16  
 
 
 
 
 
 
 
 
 
